Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Peringkat dalam Saham #40617
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Harga Saham
$1.06
Terakhir disinkronkan: 2021-06-25
Kapitalisasi Pasar
$110.93K
Perubahan (1 hari)
-5.36%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Millendo Therapeutics, Inc. (MLND)

Kategori

Riwayat hasil dividen untuk Millendo Therapeutics, Inc. (MLND)
Hasil dividen (TTM) dari Millendo Therapeutics, Inc. (simbol saham: MLND) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Millendo Therapeutics, Inc. (MLND) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing